Início › Transtorno Depressivo Maior › Flórida › Tampa
Ensaios clínicos de Transtorno Depressivo Maior em Tampa, FL
17 estudos para Transtorno Depressivo Maior estão buscando participantes em locais em Tampa e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RecrutandoFase 3
- IPTB Clinical Research, Tampa
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
RecrutandoFase 3
- Psych Me Medical Research Inc, Tampa
- Interventional Psychiatry of Tampa Bay, Tampa
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecrutandoFase 2
- K2 Medical Research - Tampa, Tampa
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
RecrutandoFase 3
- Interventional Psychiatry of Tampa Bay, Tampa
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecrutandoFase 3
- K2 Medical Research Tampa, Tampa
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecrutandoFase 4
- Neurocrine Clinical Site, Tampa
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
RecrutandoFase 2
- IPTB Clinical Research, Tampa
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
RecrutandoFase 2
- Draig Clinical Site, Tampa
- Draig Clinical Site, Tampa
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Recrutando
- USF Health, Tampa
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecrutandoFase 3
- Neurocrine Clinical Site, Tampa
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RecrutandoFase 3
- K2 Medical Research (Tampa), Tampa
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
RecrutandoFase 3
- K2 Medical Research - Tampa, Tampa
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecrutandoFase 3
- Neurocrine Clinical Site, Tampa
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecrutandoFase 3
- Neurocrine Clinical Site, Tampa
- Neurocrine Clinical Site, Tampa
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecrutandoFase 2
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
RecrutandoFase 2
- Autobahn Site #148, Tampa
Study of ALTO-300 in MDD
RecrutandoFase 2
- Site 221, Tampa
Ensaios de Transtorno Depressivo Maior em outras cidades
- New York City, NY37 estudos
- Boston, MA31 estudos
- Atlanta, GA25 estudos
- Philadelphia, PA23 estudos
- Orlando, FL19 estudos
- Miami, FL18 estudos
- Chicago, IL17 estudos
- Houston, TX16 estudos
- San Diego, CA16 estudos
- Little Rock, AR14 estudos
- Orange, CA13 estudos
- Austin, TX13 estudos
Outros estudos em Tampa
- Câncer de Pulmão de Não Pequenas Células51 estudos
- Câncer de Mama43 estudos
- Câncer (todos os tipos)39 estudos
- Câncer Colorretal33 estudos
- Câncer Metastático29 estudos
- Câncer de Pulmão29 estudos
- Leucemia Mieloide Aguda29 estudos
- Câncer de Pâncreas26 estudos
- Câncer de Ovário21 estudos
- Síndromes Mielodisplásicas19 estudos
- Melanoma19 estudos
- Insuficiência Cardíaca18 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.